The Department of Health and Human Services today withdrew a Trump Administration rule that would require the agency to assess periodically each regulation to determine whether it has a significant economic impact on a substantial number of small entities and, if so, determine whether to retain, modify or eliminate the regulation. HHS last October proposed withdrawing the rule, which was scheduled to take effect Sept. 22 after a previous one-year delay. AHA supports withdrawing the rule because it does not provide an adequate mechanism for obtaining public input on the substance of the regulations reviewed. Plaintiffs last year filed a lawsuit seeking to overturn the rule. 
 

Related News Articles

News
As proposed yesterday by its Advisory Committee on Immunization Practices, the Centers for Disease Control and Prevention recommends that starting this fall…
Headline
The 5th Circuit Court of Appeals should reverse the Federal Trade Commission’s decision in Illumina Inc. v. FTC, “a paradigmatic example” of how the agency’s…
Headline
The Food and Drug Administration on May 3 approved the first U.S. vaccine for respiratory syncytial virus, Arexvy by GlaxoSmithKline Biologicals, for use…
Headline
As urged by the AHA, the U.S. Supreme Court today unanimously reversed a 9th Circuit decision that impliedly stripped federal district courts of…
Headline
The White House today released additional details related to President Biden’s budget request for fiscal year 2024. The main budget documents were released…
Headline
The U.S. District Court for the District of Connecticut this week largely dismissed a lawsuit alleging that Yale New Haven Hospital violated its fiduciary…